physIQ Heart Rhythm and Respiratory Module vs VX1

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
VS
by Volta Medical

AI Verdict

Tool A focuses on continuous remote monitoring using wearable biosensor data to detect early signs of physiological changes, including atrial fibrillation. In contrast, Tool B provides real-time AI-guided assistance to cardiac electrophysiologists during atrial fibrillation and atrial tachycardia ablation procedures, analyzing intra-procedural electrogram data. Therefore, while both are cardiology AI tools addressing AFib, they serve distinct purposes in different phases of patient care.

Choose physIQ Heart Rhythm and Respiratory Module if…

Choose physIQ Heart Rhythm and Respiratory Module if you require continuous, long-term remote monitoring of patients using wearable biosensors. This tool is ideal for detecting subtle physiological changes and early signs of decompensation by learning individual patient baselines, making it suitable for managing chronic conditions or post-discharge surveillance.

View physIQ Heart Rhythm and Respiratory Module →

Choose VX1 if…

Choose Volta Medical's VX1 if your primary need is real-time, AI-guided assistance during atrial fibrillation and atrial tachycardia ablation procedures. This software is specifically designed to help cardiac electrophysiologists identify dispersed electrograms within the EP lab, aiming to reduce inter-operator variability and standardize procedural outcomes.

View VX1 →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature physIQ Heart Rhythm and Respiratory Module VX1
Pricing Contact for pricing Contact for pricing
Deployment Cloud-based platform Software integrated with existing electrophysiology (EP) lab mapping and recording systems.
BAA Available Yes AI-estimated Unknown
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

physIQ Heart Rhythm and Respiratory Module

Tool A (physIQ) offers broader usability, catering to both patients with wearable devices and a mobile app for continuous data collection, and clinicians with a management dashboard for actionable insights. This emphasizes ease of use for remote monitoring. Tool B (Volta Medical) provides specialized usability for electrophysiologists within complex interventional procedures, offering real-time visual and sound cues integrated into existing lab systems, which, while intuitive for specialists, is a narrower scope of user interaction.

Clinical Value

physIQ Heart Rhythm and Respiratory Module

Both tools demonstrate strong clinical value with FDA clearance and published studies. Tool A (physIQ) offers broad, proactive, and predictive value across multiple conditions through continuous monitoring, with proven ability to predict heart failure hospitalization up to 10 days in advance. Tool B (Volta Medical) provides highly targeted, real-time interventional value by improving the efficacy and standardization of complex cardiac ablation procedures. However, physIQ's broader applicability and proven early prediction capabilities give it a slight edge in overall clinical value.

Pricing & Value

Tie

Both Tool A (physIQ) and Tool B (Volta Medical) explicitly state 'contact for pricing' in their specifications. No public information was found regarding their specific pricing models, costs, or value propositions. Therefore, it is impossible to distinguish between them on pricing transparency or perceived value.

Enterprise Readiness

physIQ Heart Rhythm and Respiratory Module

Tool A (physIQ) explicitly states it is an 'enterprise-ready cloud platform,' is HIPAA compliant, has a BAA, and is FDA-cleared, along with being CFR Part 11-compliant. These are crucial indicators for seamless integration into large healthcare systems. While Tool B (Volta Medical) is FDA-cleared and integrates with existing EP lab systems, it lacks explicit public statements regarding BAA and HIPAA compliance, which are fundamental for enterprise adoption in healthcare.

Innovation

VX1

Both tools are highly innovative. Tool A (physIQ) pioneers AI-based personalized physiology analytics from continuous wearable data to detect subtle changes and early decompensation. Tool B (Volta Medical) stands out as the first commercially available AI software for real-time identification of dispersed electrograms during complex AFib/AT ablation procedures, aiming to standardize outcomes and reduce variability. Its recognition with the prestigious Prix Galien Award for Best Startup further highlights its groundbreaking innovation in a specialized interventional context.

Support & Docs

VX1

Tool B (Volta Medical) explicitly mentions and provides access to formal documentation, such as a 'VX1 SYSTEM USER MANUAL' and an 'Instructions For Use (IFU)' section on its website. Tool A (physIQ) does not have readily available public information regarding its dedicated support channels or detailed documentation beyond what is implied for technical integration in FDA documents. Therefore, Tool B appears to offer more transparent and accessible documentation.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature physIQ Heart Rhythm and Respiratory Module VX1
Name physIQ Heart Rhythm and Respiratory Module VX1
Company physIQ Volta Medical
Tagline The leader in digital medicine, dedicated to generating unprecedented health insight using continuous wearable biosensor data and advanced analytics. Transforming EP Data into AI Solutions
Primary Use Case Generating health insight using continuous wearable biosensor data, detecting subtle physiological changes and early signs of decompensation, including atrial fibrillation and respiration rate. Real-time identification of dispersed electrograms during atrial fibrillation and atrial tachycardia ablation procedures to assist cardiac electrophysiologists.
Data Input/Source Continuous wearable biosensor data 3D anatomical and electrical maps of human atria, compatible with most EP recording, 3D navigation systems, and mapping catheters.

Videos

Demos, reviews, and walkthroughs featuring physIQ Heart Rhythm and Respiratory Module and VX1.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Tool A is designed for continuous remote monitoring using wearable biosensor data to detect subtle physiological changes, early signs of decompensation, atrial fibrillation, and determine respiration rate across cardiology, critical care, and pulmonology specialties. Tool B, VX1, is specifically an AI software that assists cardiac electrophysiologists in real-time identification of dispersed electrograms during atrial fibrillation and atrial tachycardia ablation procedures.
Tool A provides AI-based personalized physiology analytics, learns individual patient baselines, detects subtle physiological changes, and calculates heart rate, heart rate variability, detects atrial fibrillation, and determines respiration rate. Tool B offers AI-guided real-time identification of dispersed electrograms (EGMs) during ablation procedures, provides cycle length estimation from electrograms, and includes a booster mode for increased sensitivity.
Tool A aims to generate unprecedented health insight using continuous wearable biosensor data and advanced analytics to detect early signs of decompensation. Tool B is designed to assist cardiologists during AFib and atrial tachycardia ablation procedures, aiming to reduce inter-operator variability and standardize outcomes.
Tool A serves a broader range of specialties including Cardiology, Critical Care, and Pulmonology. Tool B is specifically tailored for Cardiology, assisting cardiac electrophysiologists during ablation procedures.
Tool A features AI-based personalized physiology analytics that learn individual patient baselines to detect subtle physiological changes. Tool B is designed to reduce inter-operator variability and standardize outcomes during ablation procedures, which can contribute to a more consistent treatment approach.
AI Tool Finder
AI-powered search. Results may not be comprehensive.